Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Norgine Pharmaceuticals Limited, Norgine House, Widewater Place, Moorhall Road, Harefield, Uxbridge, UB9 6NS, UK
Setofilm 4 mg Orodispersible Films.
| Pharmaceutical Form |
|---|
|
Orodispersible Film. Setofilm 4 mg Orodispersible Film: White, rectangular (size 3 cm²), orodispersible film. |
Setofilm 4 mg Orodispersible Films:
Each film contains 4 mg of ondansetron (as base).
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Ondansetron |
Ondansetron is a potent, highly selective 5HT3 receptor-antagonist. Its precise mode of action in the control of nausea and vomiting is not known. |
| List of Excipients |
|---|
|
Poly (vinyl alcohol) |
The primary packaging material is a sachet, which will be opened and removed before application. The material is a composite foil composed of kraft paper (outer layer), LDPE, aluminium foil and Surlyn (inner layer).
Pack size of 2, 4, 6, 10, 30 and 50.
Not all pack sizes may be marketed.
Norgine Pharmaceuticals Limited, Norgine House, Widewater Place, Moorhall Road, Harefield, Uxbridge, UB9 6NS, UK
PL 20011/0041
11/05/2010
| Drug | Countries | |
|---|---|---|
| SETOFILM | Spain, France, Italy, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
